[{"Assets_0_Q3_USD":168287000.0,"CommonStockSharesOutstanding_0_Q3_shares":168575504.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-59805000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":941000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":7774000.0,"StockholdersEquity_0_Q3_USD":128134000.0,"Ticker":"CLDX","CIK":"744218","name":"CELLDEX THERAPEUTICS, INC.","OfficialName":"Celldex Therapeutics Inc.","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1601609341.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]